← Back
Data updated: Mar 10, 2026
OYSTER POINT PHARMA
Ophthalmology
OYSTER POINT PHARMA is a pharmaceutical company focused on Ophthalmology. Key products include TYRVAYA.
2021
Since
1
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Ophthalmology 100%
1 drugs Phase 3: 1 Phase 2: 6 Phase 1: 2
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-10-15
- Latest
- 2024-02-02
- Applications
- 1